A macrophage gene-regulatory network linked to clinical severity of coronary artery disease : The STARNET and

Lijiang Ma1,2, Jacqueline E Tamis-Holland3, Giuseppe Mocci4

  • 1Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

PubMed

Insights

Coronary artery disease (CAD) is a major global health issue. This study identified a macrophage gene regulatory network (GRNGREEN) causally linked to CAD severity, offering potential therapeutic targets like NEIL1.

Area of Science:

  • Genetics and Systems Biology
  • Cardiovascular Disease Research
  • Immunology and Macrophage Biology

Background:

  • Coronary artery disease (CAD) is a leading cause of mortality worldwide.
  • Macrophages are key players in the pathogenesis of CAD.
  • Understanding macrophage gene regulatory networks (GRNs) is crucial for CAD research.

Purpose of the Study:

  • To explore and validate the role of macrophage GRNs in clinically significant CAD.
  • To identify key driver genes within these networks associated with CAD severity.
  • To assess the heritability contribution and therapeutic potential of identified GRNs.

Main Methods:

  • Integrative systems genetics analysis of primary blood macrophage RNA sequencing (RNAseq) data from STARNET and NGS-PREDICT studies.
  • Inference of macrophage GRNs, differential gene expression analysis, and identification of key driver genes.
  • Analysis of expression quantitative traits (eQTLs), genome-wide association studies (GWAS), and retrospective/prospective validation in independent datasets.

Main Results:

  • Identified 23 macrophage GRNs, with GRNGREEN significantly associated with CAD severity (SYNTAX score).
  • GRNGREEN comprises 729 genes, 90 key drivers (top: NEIL1), accounts for 3.73% of CAD heritability, and contains 34 known CAD GWAS genes.
  • GRNGREEN involves SRP-dependent co-translational protein targeting to the membrane and was validated in multiple independent datasets.

Conclusions:

  • GRNGREEN is causally associated with CAD severity and contributes significantly to CAD heritability.
  • NEIL1 is identified as a top key driver gene within GRNGREEN.
  • GRNGREEN and NEIL1 represent potential therapeutic targets for preventing and treating CAD by modulating macrophage function.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
42
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
26
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.4K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
67
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
38
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
222